Search for content, post, videos

Follicum pauses all of its development projects

Jan Alenfall
Following results from a phase 2 study of FOL-005, for the treatment of hair loss, the Board of the company decided to evaluate the company's business strategy and long-term goals. The board of Follicum has now estimated that the company, in its current situation, will have difficulties in attrac
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.